Clinical Trials Directory

Trials / Completed

CompletedNCT03712475

Pharmacokinetics of Two Formulation of Pregabalin

A Randomized, Single-dose, Parallel-group Study to Evaluate the Pharmacokinetic Profiles of Two Formulation of Pregabalin in Healthy Volunteers Under Fasting Conditions

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Yung Shin Pharm. Ind. Co., Ltd. · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

A Randomized, Single-Dose, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of Two Formulations of Pregabalin after Oral Administration in Healthy Volunteers under Fasting Conditions

Conditions

Interventions

TypeNameDescription
DRUGPregabalinpharmacokinetic study under fasting conditions

Timeline

Start date
2018-01-19
Primary completion
2018-09-16
Completion
2018-12-03
First posted
2018-10-19
Last updated
2019-01-28

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03712475. Inclusion in this directory is not an endorsement.